Enter your Contact information to join 
Ault Life Sciences
I am an Accredited Investor ( Earn over $200k a year or $1Million in Net worth)
CUSTOM JAVASCRIPT / HTML
* we will not spam, rent, or sell your information... *
Why Ault Life Sciences?
  • Working towards Global Impact
  • Led by a 30 year Wall Street Veteran
  • Amazing Partners in the Biotech Industry
  • Opportunity for impactful investing
A message from our CEO Milton "Todd" Ault III
"In my 30 years on Wall Street, I have come to understand the risks and rewards associated with investing in innovative life science companies. Having benefited from numerous successful transactions in this sector, I have now created a new venture, Ault Life Sciences. This was done to both support a promising new company (Alzamend Neuro) in advancing two treatments for Alzheimer’s disease and to uncover additional promising companies and technologies with a focus on treating neuro-degenerative diseases. Our leadership team and network of scientific experts are in position as we look to capture the tremendous upside potential of the life sciences sector. "

Milton "Todd" Ault III,
Founder/Executive Chairman Ault Life Sciences, Inc
What Seperates Ault Life Science from other Companies?
Two Drugs with Amazing Promise
Two drugs, AL001 and AL002, have promising results and are ready for clinical trials in humans today.
Experience
Seasoned leadership team including industry experts. CEO Todd Ault has been a leader and investor in the biotech industry for years with proven results. 
Leadership
A team that not only has experience, but a passion to find effective treatments and potential cures for Alzheimer’s and other neurodegenerative diseases and psychiatric disorders.
Partners
- Alzamend Neuro
- University of South Florida
- Network of Scientific Experts in the Neuro-degenerative space
Are you ready to Join the Fight with Todd?
Copyright 2020 Ault Life Sciences, Inc All Rights Reserved

Important Legal Notice and Disclaimer: Ault Life Science, Inc. does not sell or share any information with other companies. Our offering will be made pursuant to Rule 506(c) of the Securities Act of 1933, and only to accredited investors. Ault Life Sciences, Inc., and its affiliates and subsidiaries (collectively, the “Company”) are not broker-dealers or investment advisers. The Company does not provide investment advice or sell securities or execute securities transactions on behalf of third parties. The Company does not advise any user on the merits or advisability of any investment or securities offering, nor does the Company provide any legal, tax, investment, or transactional advisory advice or services. The information provided on the website is not intended to be an offer, solicitation or recommendation by the Company to buy or sell any investment instruments or enter into any other type of transaction, nor shall it be considered investment advice.